MYC + DLBCL patients demonstrate different response patterns compared to MYC- DLBCL patients with more progressive disease during treatment after I-PET negative assessment, with more nodal and extranodal lesions at sites that were not initially involved. Here, MYC is linked to diffuse large B-cell lymphoma.